Mitomycin as a Hyperthermic Peritoneal Perfusion in Treating Patients With Malignant Ascites

NCT00265863 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Withdrawn due to slow accrual

Conditions

Metastatic Cancer

Interventions

DRUG: mitomycin C

Sponsor

Masonic Cancer Center, University of Minnesota